Purpose To elucidate the long-term impacts of hearing loss, tinnitus and balance in people
living with and beyond cancer (LWBC) treated with platinum-based chemotherapy (PBCT) …

Purpose This study aimed to explore the burden of inner ear damage (ototoxicity) on adults
living with and beyond cancer treated with chemotherapy and the impact on their quality of …

Objective: To identify any change in quality of life (QoL) caused by chemotherapy-induced
toxicities, such as hearing loss and tinnitus, to provide information in order to improve …

Introduction Ototoxicity associated with platinum-based chemotherapy is highly prevalent
and can cause detrimental consequences among cancer survivors. Discussion In this article …

Purpose Limited information is available on the impact of chemotherapy (CTX)-induced
neurotoxicity on adult survivors' symptom experience and quality of life (QOL). Purposes …

Purpose Ototoxicity is a prominent side effect of cisplatin-based chemotherapy. There are
few reports, however, estimating its prevalence in well-defined cohorts and associated risk …

PURPOSE Cisplatin is widely used and highly ototoxic, but patient-reported functional
impairment because of cisplatin-related hearing loss (HL) and tinnitus has not been …

Objectives Little is known about hearing loss and tinnitus associated with neurotoxic
chemotherapy. Study evaluated for differences in occurrence rates and effects of hearing …

Cancer therapies may cause hearing loss (HL) in some patients. The purpose of this study is
to examine at risk factors for HL and its impact on the health of a large cohort of cancer …

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based
Chemotherapy in Survivors of Adult-Onset Cancer - PMC Back to Top Skip to main content NIH …